96 related articles for article (PubMed ID: 6693771)
1. Natural release of covalently bound C3b from cell surfaces and the study of this phenomenon in the fluid-phase system.
Venkatesh YP; Minich TM; Law SK; Levine RP
J Immunol; 1984 Mar; 132(3):1435-9. PubMed ID: 6693771
[TBL] [Abstract][Full Text] [Related]
2. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
Melamed J; Medicus RG; Arnaout MA; Colten HR
J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
[TBL] [Abstract][Full Text] [Related]
3. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release.
Melamed J; Arnaout MA; Colten HR
J Immunol; 1982 May; 128(5):2313-8. PubMed ID: 6801135
[TBL] [Abstract][Full Text] [Related]
4. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.
Mann J; O'Brien R; Hostetter MK; Alper CA; Rosen FS; Babior BM
J Immunol; 1981 Jun; 126(6):2370-2. PubMed ID: 6785350
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
Arnaout MA; Melamed J; Tack BF; Colten HR
J Immunol; 1981 Oct; 127(4):1348-54. PubMed ID: 7276561
[TBL] [Abstract][Full Text] [Related]
7. Behavior of soluble human 125I-labeled C3b, the third component of complement, after binding to human cells.
Charriaut C; Barel M; Frade R
Eur J Immunol; 1982 Apr; 12(4):289-94. PubMed ID: 6980121
[TBL] [Abstract][Full Text] [Related]
8. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
Isenman DE; Podack ER; Cooper NR
J Immunol; 1980 Jan; 124(1):326-31. PubMed ID: 7350230
[TBL] [Abstract][Full Text] [Related]
9. Binding reaction between the third human complement protein and small molecules.
Law SK; Minich TM; Levine RP
Biochemistry; 1981 Dec; 20(26):7457-63. PubMed ID: 7326238
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of the covalent bond of C3b-/C3-small-molecule complexes under physiological conditions.
Venkatesh YP; Minich TM; Levine RP
Ann N Y Acad Sci; 1983; 421():313-5. PubMed ID: 6586105
[No Abstract] [Full Text] [Related]
11. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.
Law SK; Lichtenberg NA; Levine RP
J Immunol; 1979 Sep; 123(3):1388-94. PubMed ID: 38283
[No Abstract] [Full Text] [Related]
12. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
[TBL] [Abstract][Full Text] [Related]
13. Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.
Leslie RG; Prodinger WM; Nielsen CH
Eur J Immunol; 2003 Dec; 33(12):3311-21. PubMed ID: 14635039
[TBL] [Abstract][Full Text] [Related]
14. Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediator.
Gordon DL; Krueger RA; Quie PG; Hostetter MK
J Immunol; 1985 May; 134(5):3339-45. PubMed ID: 3980996
[TBL] [Abstract][Full Text] [Related]
15. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
[TBL] [Abstract][Full Text] [Related]
16. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
Rawal N; Pangburn MK
Mol Immunol; 2007 Feb; 44(6):1105-14. PubMed ID: 16979240
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic studies on the aminopeptidase from Aeromonas proteolytica: a two-metal ion mechanism for peptide hydrolysis.
Chen G; Edwards T; D'souza VM; Holz RC
Biochemistry; 1997 Apr; 36(14):4278-86. PubMed ID: 9100023
[TBL] [Abstract][Full Text] [Related]
18. Enhanced recognition of plasma proteins in a non-native state by complement C3b. A possible clearance mechanism for damaged proteins in blood.
Ramadass M; Ghebrehiwet B; Kew RR
Mol Immunol; 2015 Mar; 64(1):55-62. PubMed ID: 25466612
[TBL] [Abstract][Full Text] [Related]
19. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
[TBL] [Abstract][Full Text] [Related]
20. The use of conglutinin in a quantitative assay for the presence of cell-bound C3bi and evidence that a single molecule of C3bi is capable of binding conglutinin.
Brown EJ; Gaither TA; Hammer CH; Hosea SW; Frank MM
J Immunol; 1982 Feb; 128(2):860-5. PubMed ID: 7033384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
